Regenerative medicine has become a key focus worldwide and the number of stem cell-based clinical trials are rapidly increasing every year. Yet, large-scale and GMP-compliant stem cell manufacturing ...

IsoPlexis, which recently received an NCI grant, reports that it has published a technology note with Miltenyi Biotec in a co-marketing agreement. The tech note (“Getting the most out of your CAR-T ...

Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR Syena, co-founded by Replay and MD Anderson in 2023, will develop an off-the-shelf PRAME TCR-NK cell therapy, with IND anticipated Q1 ...

The CliniMACS Prodigy, a device designed to manufacture cellular products used in cell-based therapies. Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact ...

Some of the most cutting-edge approaches to treating cancer over the past decade arose from personalized immunotherapy. Chimeric antigen receptor (CAR) T cells can be engineered to specifically target ...